|
Loading...
| ||||||||||||||
Recent Publications by Biovation Ltd: |  | |
| Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
BACKGROUND: The development of inhibitors in hemophiliacs is a severe... | Biovation | J Thromb Haemost. 2005 May;3(5):991-1000.
DOI Direct Link |
| The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection.
Interferon-alpha (IFN-alpha), in conjunction with ribavirin, is the... | Biovation | J Interferon Cytokine Res. 2004 Sep;24(9):560-72.
DOI Direct Link |
Biovation Ltd Patents: |  |
| US Patent No. | Title |
| 7264806 | Modified anti-CD52 antibody |
| 7125689 | Method for rendering streptokinase less immunogenic to a human |
| 6974699 | Pharmaceuticals and assays using enzyme subunits |
| 6927025 | Methods for protein screening |
| 6472365 | Pharmaceuticals and assays using enzyme subunits |